Patients in Boston wait the longest for an appointment with an obstetrician/gynecologistan average of 45 dayscompared to those in 14 other metropolitan areas. In contrast, patients in Miami wait the least amount of timean average of 10 days, according to a survey conducted by a national physician search and consulting firm.
Posing as new patients, survey researchers from Merritt, Hawkins & Associates tried to make appointments for routine gynecologic exams in doctors' offices in 15 metropolitan areasAtlanta, Boston, Dallas, Denver, Detroit, Houston, Los Angeles, Miami, Minneapolis, New York, Philadelphia, Portland, San Diego, Seattle, and Washington, D.C.
Among all the cities surveyed, the average time to get an appointment with an ob/gyn was 23.3 days. In 13 of the 15 cities, average wait times were 14 days or more. In eight of the 15 cities, average wait times exceeded 21 days.
According to the Irving, Texas-based firm, physician practices that are booked more than 14 days out are considered busy and may need to consider adding a new associate. In addition, accessibility to physicians becomes a problemone that may force privately insured patients to seek non-emergent care in hospital emergency rooms.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More